These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18187580)

  • 41. High-affinity binding of tumor-suppressor protein p53 and HMGB1 to hemicatenated DNA loops.
    Stros M; Muselíková-Polanská E; Pospísilová S; Strauss F
    Biochemistry; 2004 Jun; 43(22):7215-25. PubMed ID: 15170359
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rate of promoter class turn-over in yeast evolution.
    Bazykin GA; Kondrashov AS
    BMC Evol Biol; 2006 Feb; 6():14. PubMed ID: 16472383
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DUSP1 is controlled by p53 during the cellular response to oxidative stress.
    Liu YX; Wang J; Guo J; Wu J; Lieberman HB; Yin Y
    Mol Cancer Res; 2008 Apr; 6(4):624-33. PubMed ID: 18403641
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Toll-like receptor gene family is integrated into human DNA damage and p53 networks.
    Menendez D; Shatz M; Azzam K; Garantziotis S; Fessler MB; Resnick MA
    PLoS Genet; 2011 Mar; 7(3):e1001360. PubMed ID: 21483755
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of a p53-response element in the promoter of the proline oxidase gene.
    Maxwell SA; Kochevar GJ
    Biochem Biophys Res Commun; 2008 May; 369(2):308-13. PubMed ID: 18279664
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Roles of USF, Ikaros and Sp proteins in the transcriptional regulation of the human reduced folate carrier B promoter.
    Liu M; Whetstine JR; Payton SG; Ge Y; Flatley RM; Matherly LH
    Biochem J; 2004 Oct; 383(Pt 2):249-57. PubMed ID: 15214842
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Species-specific endogenous retroviruses shape the transcriptional network of the human tumor suppressor protein p53.
    Wang T; Zeng J; Lowe CB; Sellers RG; Salama SR; Yang M; Burgess SM; Brachmann RK; Haussler D
    Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18613-8. PubMed ID: 18003932
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of p53 transactivation domain mutants reveals Acad11 as a metabolic target important for p53 pro-survival function.
    Jiang D; LaGory EL; Kenzelmann Brož D; Bieging KT; Brady CA; Link N; Abrams JM; Giaccia AJ; Attardi LD
    Cell Rep; 2015 Feb; 10(7):1096-109. PubMed ID: 25704813
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiple response elements and differential p53 binding control Perp expression during apoptosis.
    Reczek EE; Flores ER; Tsay AS; Attardi LD; Jacks T
    Mol Cancer Res; 2003 Dec; 1(14):1048-57. PubMed ID: 14707288
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of human guanylate-binding protein 1 gene (hGBP1) as a direct transcriptional target gene of p53.
    Zhu Z; Wei J; Shi Z; Yang Y; Shao D; Li B; Wang X; Ma Z
    Biochem Biophys Res Commun; 2013 Jun; 436(2):204-11. PubMed ID: 23727578
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel p53 mutational hotspot in skin tumors from UV-irradiated Xpc mutant mice alters transactivation functions.
    Inga A; Nahari D; Velasco-Miguel S; Friedberg EC; Resnick MA
    Oncogene; 2002 Aug; 21(37):5704-15. PubMed ID: 12173040
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interaction of human polyomavirus BK with the tumor-suppressor protein p53.
    Shivakumar CV; Das GC
    Oncogene; 1996 Jul; 13(2):323-32. PubMed ID: 8710371
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comprehensive Expression Profiling and Functional Network Analysis of p53-Regulated MicroRNAs in HepG2 Cells Treated with Doxorubicin.
    Yang Y; Liu W; Ding R; Xiong L; Dou R; Zhang Y; Guo Z
    PLoS One; 2016; 11(2):e0149227. PubMed ID: 26886852
    [TBL] [Abstract][Full Text] [Related]  

  • 55. p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription.
    Innocente SA; Lee JM
    FEBS Lett; 2005 Feb; 579(5):1001-7. PubMed ID: 15710382
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A/T gap tolerance in the core sequence and flanking sequence requirements of non-canonical p53 response elements.
    Cai BH; Chao CF; Lin HC; Huang HY; Kannagi R; Chen JY
    J Biochem; 2016 Jun; 159(6):563-72. PubMed ID: 26823482
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Divergence of the PIERCE1 expression between mice and humans as a p53 target gene.
    Kim HJ; Lee SE; Na H; Roe JS; Roh JI; Lee HW
    PLoS One; 2020; 15(8):e0236881. PubMed ID: 32745107
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evolutionary origins of human apoptosis and genome-stability gene networks.
    Castro MA; Dalmolin RJ; Moreira JC; Mombach JC; de Almeida RM
    Nucleic Acids Res; 2008 Nov; 36(19):6269-83. PubMed ID: 18832373
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comprehensive and high-resolution genome-wide response of p53 to stress.
    Chang GS; Chen XA; Park B; Rhee HS; Li P; Han KH; Mishra T; Chan-Salis KY; Li Y; Hardison RC; Wang Y; Pugh BF
    Cell Rep; 2014 Jul; 8(2):514-27. PubMed ID: 25043190
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transactivation by temperature-dependent p53 mutants in yeast and human cells.
    Slovackova J; Grochova D; Navratilova J; Smarda J; Smardova J
    Cell Cycle; 2010 Jun; 9(11):2141-8. PubMed ID: 20505364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.